HALO
Halozyme Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
HALO Filings
Filing Date
Form Description
Form Type
2025-12-01
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-01 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-01
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-01 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-24
Form 8-K - Current report
Key Events
2025-11-24 · Key Events
Form 8-K - Current report
2025-11-18
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2025-11-18 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2025-11-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-07
Form 8-K - Current report
Key Events
2025-11-07 · Key Events
Form 8-K - Current report
2025-11-05
Form 8-K - Current report
Key Events
2025-11-05 · Key Events
Form 8-K - Current report
2025-11-03
Halozyme Therapeutics, Inc. (HALO) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-03 · Earnings Call
Halozyme Therapeutics, Inc. (HALO) Q3 2025 Earnings Call Transcript
